Published September 8, 2021 | Version v1
Journal article Open

Is tirzepatide in the surpass lane over GLP-1 receptor agonists for the treatment of diabetes?

  • 1. Center for Molecular Cardiology, University of Zürich, Switzerland and University Heart Center, University Hospital Zurich, Zürich, Switzerland
  • 2. Department of Pharmacology, Catholic University School of Medicine, Rome, Italy

Description

n/a

Files

fulltext.pdf

Files (225.9 kB)

Name Size Download all
md5:20e37323ea069d6784c53cfa7479e47f
225.9 kB Preview Download